Akari Therapeutics
Akari Therapeutics
akaritx.com

Locations

London, UK

industry

Biotechnology · DeepTech · Health

Size

11-50 employees

Stage

IPO

founded in

2015

Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The company develops life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways. Akari Therapeutics was founded in 2015 and is headquartered in London, England.

Something looks off?
Open jobs at Akari Therapeutics
Powered by Getro